Barinthus Biotherapeutics (BRNS) Other Working Capital Changes (2020 - 2026)
Barinthus Biotherapeutics' (BRNS) quarterly Other Working Capital Changes came in at -$347000.0 in Q1 2026, up 27.41% YoY from -$272358.0 in Q1 2025, and up 30.88% on a QoQ basis from -$502000.0 in Q4 2025.
Barinthus Biotherapeutics (BRNS) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Barinthus Biotherapeutics (BRNS) has 7 years of Other Working Capital Changes data on file, last reported at -$347000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 27.41% year-over-year to -$347000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.8 million (up 3.8% YoY) and the FY2025 annual result came in at -$2.0 million, down 10.62% from the prior year.
- Other Working Capital Changes improved to -$347000.0 in Q1 2026, from -$502000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $6.0 million in Q2 2022 to a low of -$4.1 million in Q1 2023.
- A 5-year average of -$6750.0 and a median of -$291500.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes jumped 386.67% — and 2023, when it sank 1134.88%.
- Tracing BRNS's Other Working Capital Changes over 5 years: stood at $43000.0 in 2022, then slumped by 1134.88% to -$445000.0 in 2023, then decreased by 8.54% to -$483000.0 in 2024, then dropped by 3.93% to -$502000.0 in 2025, then surged by 30.88% to -$347000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$347000.0 (Q1 2026), -$502000.0 (Q4 2025), and -$504000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Barinthus Biotherapeutics | 25.40 Mn | 25.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -958,000.00 |
| Jun 30, 2026 | -958,000.00 |
| Jun 30, 2026 | -958,000.00 |
| Mar 31, 2026 | -347,000.00 |
| Mar 31, 2026 | -347,000.00 |
| Mar 31, 2026 | -347,000.00 |
| Dec 31, 2025 | -502,000.00 |
| Dec 31, 2025 | -502,000.00 |
| Dec 31, 2025 | -502,000.00 |
| Sep 30, 2025 | -504,000.00 |
| Sep 30, 2025 | -504,000.00 |
| Sep 30, 2025 | -504,000.00 |
| Jun 30, 2025 | -495,000.00 |
| Jun 30, 2025 | -495,000.00 |
| Jun 30, 2025 | -495,000.00 |
| Mar 31, 2025 | -478,000.00 |
| Mar 31, 2025 | -478,000.00 |
| Mar 31, 2025 | -478,000.00 |
| Dec 31, 2024 | -483,000.00 |
| Dec 31, 2024 | -483,000.00 |